Join us at this symposium to hear the latest clinical data for tirzepatide (Mounjaro®).
In particular, A/Professor Glastras will present key data from the weight management registration studies, notably SURMOUNT-1 and SURMOUNT-4, a new delivery modality, and emerging real-world evidence data from international data sources. In addition, practical tips and considerations for commencing patients successfully on this first-in-class medicine will be provided.
Confirmed Speaker: Associate Professor Sarah Glastras
Breakfast is included as part of this session outside the room.
ANZBMS President: Mark Cooper